|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.339
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.266
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.248
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.246
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.218
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.190
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.174
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.173
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.167
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.167
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.163
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.162
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.151
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.138
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.137
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.135
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.134
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.133
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.132
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.128
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.127
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.124
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.123
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.117
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.115
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.115
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.113
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.112
|
|
|
|
intermediate filament organization
|
GO:0045109 |
15 |
0.108
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.102
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.097
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.097
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.094
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.093
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.090
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.090
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.089
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.089
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.086
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.086
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.086
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.085
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.085
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.084
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.084
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.082
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.082
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.081
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.081
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.079
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.079
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.079
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.078
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.077
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.077
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.077
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.076
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.075
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.075
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.074
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.073
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.073
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.073
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.073
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.072
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.072
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.070
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.070
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.069
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.069
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.069
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.068
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.068
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.068
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.068
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.067
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.066
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.065
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.065
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.064
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.064
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.063
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.063
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.062
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.061
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.061
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.061
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.061
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.061
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.061
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.060
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.060
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.059
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.058
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.058
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.058
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.057
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.057
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.057
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.057
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.056
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.055
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.055
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.055
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.055
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.054
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.054
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.053
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.053
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.053
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.053
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.052
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.052
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.052
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.051
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.051
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.051
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.051
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.051
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.051
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.051
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.050
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.050
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.050
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.049
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.049
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.049
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.049
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.049
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.049
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.049
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.049
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.048
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.048
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.048
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.047
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.047
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.046
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.046
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.045
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.044
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.044
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.044
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.044
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.044
|
|
|
|
translation
|
GO:0006412 |
93 |
0.043
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.043
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.043
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.042
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.042
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.042
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.042
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.042
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.042
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.042
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.041
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.041
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.041
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.041
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.041
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.040
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.040
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.040
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.040
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.040
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.040
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.040
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.040
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.039
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.039
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.039
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.039
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.039
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.039
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.039
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.038
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.038
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.038
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.038
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.038
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.038
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.038
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.038
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.038
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.038
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.038
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.037
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.037
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.037
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.037
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.037
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.037
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.037
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.037
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.037
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.037
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.037
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.036
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.036
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.036
|
|
|
|
positive regulation of hair follicle development
|
GO:0051798 |
6 |
0.036
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.036
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.036
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.036
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.036
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.036
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.036
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.036
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.036
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.035
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.035
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.035
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.035
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.035
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.035
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.035
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.035
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.034
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.034
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.034
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.034
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.034
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.034
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.034
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.034
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.034
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.033
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.033
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.033
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.033
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.033
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.033
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.033
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.032
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.032
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.032
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.032
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.032
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.032
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.032
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.032
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.032
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.032
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.031
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.031
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.031
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.031
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.031
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.031
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.031
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.031
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.031
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.031
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.031
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.031
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.031
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.031
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.030
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.030
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.030
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.030
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.030
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.030
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.030
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.030
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.030
|
|
|
|
positive regulation of smoothened signaling pathway
|
GO:0045880 |
23 |
0.030
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.030
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.029
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.029
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.029
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.029
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.029
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.029
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.029
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.029
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.028
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.028
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.028
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.028
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.028
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.028
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.028
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.028
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.028
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.028
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.028
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.027
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.027
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.027
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.027
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.027
|
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
22 |
0.027
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.027
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.027
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.027
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.027
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.027
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.027
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.027
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.027
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.027
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.026
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.026
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.026
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.026
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.026
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.026
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.026
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.026
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.026
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.026
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.026
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.026
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.026
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.025
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.025
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.025
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.025
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.025
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.025
|
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.025
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.025
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.025
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.025
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.025
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.025
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.025
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.025
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.025
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.025
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.025
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.025
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.024
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.024
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.024
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.024
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.024
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.024
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.024
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.024
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.024
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.024
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.024
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.024
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.024
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.024
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.024
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.024
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.024
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.024
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.023
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.023
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.023
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.023
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.023
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.023
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.023
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.023
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.023
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.023
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.023
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.023
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.023
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.023
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.023
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.023
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.023
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.023
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.023
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.023
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.023
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.023
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.022
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.022
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.022
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.022
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.022
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.022
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.022
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.022
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.022
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.022
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.021
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.021
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.021
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.021
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.021
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.021
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.021
|
|
|
|
sensory neuron axon guidance
|
GO:0097374 |
3 |
0.021
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.021
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.021
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.021
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.021
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.021
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.021
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.021
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.021
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.021
|
|
|
|
corticotropin hormone secreting cell differentiation
|
GO:0060128 |
3 |
0.021
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.021
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.020
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.020
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.020
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000433 |
1 |
0.020
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.020
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.020
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.020
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.020
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.020
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.020
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.020
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.020
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.020
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.020
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.020
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
28 |
0.020
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.020
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.020
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.020
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.019
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.019
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.019
|
|
|
|
regulation of membrane depolarization during cardiac muscle cell action potential
|
GO:1900825 |
1 |
0.019
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.019
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.019
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.019
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.019
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.019
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.019
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.019
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.019
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.019
|
|
|
|
regulation of hair cycle
|
GO:0042634 |
11 |
0.019
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.019
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.019
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.019
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.019
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.019
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.019
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.019
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.019
|
|
|
|
positive regulation of translation
|
GO:0045727 |
19 |
0.019
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.019
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.019
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.019
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.019
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.018
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.018
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.018
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.018
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.018
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.018
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.018
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.018
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.018
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.018
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.018
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.018
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.018
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.018
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.018
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.018
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.018
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.018
|
|
|
|
adenohypophysis development
|
GO:0021984 |
14 |
0.018
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.018
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.018
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.018
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.018
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.018
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.018
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.018
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.018
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.018
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.018
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.018
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.018
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.018
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.018
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.018
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.017
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.017
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.017
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.017
|
|
